SA517390074B1 - إبرة حقن لوقف النزف مغلفة بكيتوزان مرتبط تشابكياً بها مجموعة كاتيكول ومجموعة كاتيكول مؤكسدة - Google Patents

إبرة حقن لوقف النزف مغلفة بكيتوزان مرتبط تشابكياً بها مجموعة كاتيكول ومجموعة كاتيكول مؤكسدة

Info

Publication number
SA517390074B1
SA517390074B1 SA517390074A SA517390074A SA517390074B1 SA 517390074 B1 SA517390074 B1 SA 517390074B1 SA 517390074 A SA517390074 A SA 517390074A SA 517390074 A SA517390074 A SA 517390074A SA 517390074 B1 SA517390074 B1 SA 517390074B1
Authority
SA
Saudi Arabia
Prior art keywords
catechol group
patients
injection needle
hemostatic
oxidized
Prior art date
Application number
SA517390074A
Other languages
English (en)
Inventor
سونج أوه سوك
سوي لي موون
شين ميكيونج
لي هايشين
Original Assignee
.انوثيربي انك
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by .انوثيربي انك filed Critical .انوثيربي انك
Publication of SA517390074B1 publication Critical patent/SA517390074B1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/02—Methods for coating medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

يتعلق الاختراع الحالي بإبرة حقن injection needle لوقف النزف مغلفة بكيتوزان chitosan يتم فيه إدخال مجموعة كاتيكول catechol ومجموعة كاتيكول مؤكسدة oxidized catechol وربطها تشابكياً. يمكن أن تعمل إبرة الحقن لوقف النزيف وفقاً للاختراع الحالي على منع النزف أثناء وبعد الحقن، ويمكن بالتالي استخدامها بفعالية للحقن ليس فقط في مرضى الاعتلال التخثري coagulopathy patients ، بما في ذلك مرضى السكري diabetic patients ، مرضى خاضعين للعلاج المضاد للسرطان anticancer ، ومرضى النزف haemophilia ، من لديهم قدرة منخضة على وقف النزف، ولكن أيضاً في مرضى يظهرون استجابات رفض الدم ، والأطفال. شكل 1.
SA517390074A 2015-04-03 2017-10-01 إبرة حقن لوقف النزف مغلفة بكيتوزان مرتبط تشابكياً بها مجموعة كاتيكول ومجموعة كاتيكول مؤكسدة SA517390074B1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150047329A KR101576503B1 (ko) 2015-04-03 2015-04-03 카테콜 기 및 산화된 카테콜 기가 도입되어 가교된 키토산으로 코팅된 무출혈 주사바늘
PCT/KR2016/003451 WO2016159734A1 (ko) 2015-04-03 2016-04-04 카테콜 기 및 산화된 카테콜 기가 도입되어 가교된 키토산으로 코팅된 무출혈 주사바늘

Publications (1)

Publication Number Publication Date
SA517390074B1 true SA517390074B1 (ar) 2021-06-24

Family

ID=55020728

Family Applications (1)

Application Number Title Priority Date Filing Date
SA517390074A SA517390074B1 (ar) 2015-04-03 2017-10-01 إبرة حقن لوقف النزف مغلفة بكيتوزان مرتبط تشابكياً بها مجموعة كاتيكول ومجموعة كاتيكول مؤكسدة

Country Status (14)

Country Link
US (1) US9931443B1 (ar)
EP (1) EP3278820B1 (ar)
JP (1) JP6410988B2 (ar)
KR (1) KR101576503B1 (ar)
CN (2) CN107530477A (ar)
AU (1) AU2016241211B2 (ar)
BR (1) BR112017020978B1 (ar)
CA (1) CA2980116C (ar)
ES (1) ES2767717T3 (ar)
IL (1) IL254614B (ar)
MX (1) MX2017012688A (ar)
RU (1) RU2674704C1 (ar)
SA (1) SA517390074B1 (ar)
WO (1) WO2016159734A1 (ar)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101576503B1 (ko) * 2015-04-03 2015-12-11 주식회사 이노테라피 카테콜 기 및 산화된 카테콜 기가 도입되어 가교된 키토산으로 코팅된 무출혈 주사바늘
KR101818229B1 (ko) * 2016-09-23 2018-01-12 한국과학기술원 즉각적인 지혈능을 보유한 무출혈 주사바늘의 제조방법
US20210060203A1 (en) * 2017-12-29 2021-03-04 Tricol Biomedical, Inc. Tissue adherent chitosan material that resists dissolution
CN108310473A (zh) * 2018-01-31 2018-07-24 采纳科技股份有限公司 注射针硅油涂层材料及涂覆此涂层的注射针
CN109620999A (zh) * 2019-01-12 2019-04-16 王若梅 一种复合止血医用组织胶的制备方法
KR102222519B1 (ko) 2019-12-31 2021-03-04 주식회사 이노테라피 자기실링이 가능한 안구의 누공억제용 주사바늘 및 그 제조방법
CN112972749B (zh) * 2021-03-05 2022-04-12 武汉纺织大学 基于壳聚糖纤维的高效止血材料及其制备方法
CN113101264B (zh) * 2021-04-08 2022-05-03 西南交通大学 一种具有ros响应的水凝胶及其制备方法和应用
CN113180788B (zh) * 2021-04-20 2023-03-21 上海交通大学医学院附属仁济医院 一种止血针的制备方法
CN114181327A (zh) * 2021-12-16 2022-03-15 四川大学 一种水溶性改性壳聚糖及其制备方法、应用
CN114209889B (zh) * 2021-12-24 2023-03-10 中山大学附属第三医院（中山大学肝脏病医院） 一种改性壳聚糖/功能性短肽复合水凝胶及其制备方法和应用
CN114767918B (zh) * 2022-03-21 2023-04-07 东莞市人民医院 一种促凝止血蛋白材料、促凝止血抗菌材料及其制备方法
CN116059437B (zh) * 2023-02-27 2023-12-19 南通大学 一种抗收缩血液接触组织粘合材料的制备方法及应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101103423B1 (ko) * 2009-09-04 2012-01-06 아주대학교산학협력단 생체 주입형 조직 접착성 하이드로젤 및 이의 생의학적 용도
US8496625B2 (en) * 2010-05-26 2013-07-30 Nxstage Medical, Inc. Safe needle methods, apparatus, and systems
US8715719B2 (en) 2010-06-16 2014-05-06 Abbott Vascular, Inc. Stable chitosan hemostatic implant and methods of manufacture
EP2611471B1 (en) * 2010-08-30 2018-10-03 President and Fellows of Harvard College A high strength chitin composite material and method of making
PL2616191T3 (pl) * 2010-09-13 2017-12-29 Chemetall Gmbh Sposób powlekania powierzchni i zastosowanie wyrobów powlekanych tym sposobem
RU2433828C1 (ru) * 2010-10-14 2011-11-20 Закрытое акционерное общество "БИОМИР сервис" Инъекционный гетерогенный биополимерный гидрогель для заместительной и регенеративной хирургии и способ его получения
KR101257996B1 (ko) * 2010-11-01 2013-04-30 아주대학교산학협력단 폴리페놀산화효소를 이용한 생리활성 물질의 표면 고정화 방법
KR101298906B1 (ko) * 2011-07-21 2013-08-20 연세대학교 산학협력단 점착성 고분자-카테콜 접합체를 이용한 생체 모방형 다층 하이드로겔 코팅 방법
US20140242870A1 (en) * 2011-09-27 2014-08-28 Postech Academy-Industry Foundation Chitosan and/or chitin composite having reinforced physical properties and use thereof
AU2011381641B2 (en) * 2011-11-21 2015-04-23 Innotherapy Inc. Hydrogel comprising catechol group-coupled chitosan or polyamine and poloxamer comprising thiol group coupled to end thereof, preparation method thereof, and hemostat using same
US20130261567A1 (en) * 2012-03-29 2013-10-03 John Lewis Hogan, III Coagulant substance which will be found at the base of a needle to reduce leakage of fluids, mainly blood from around the insertion base of a needle
CN102813963A (zh) * 2012-09-10 2012-12-12 高长有 一种以多巴胺为桥连的生物医用材料表面固定功能分子的方法
JP5188646B1 (ja) 2012-09-20 2013-04-24 株式会社フジコーポレーション 無機廃棄物固化シールド構造体および無機廃棄物固化シールド構造体の製造方法
CN103191467B (zh) * 2013-04-07 2014-07-02 西南交通大学 医用金属表面固定多种细胞生长因子抗菌涂层的制备方法
US9581536B2 (en) * 2013-05-09 2017-02-28 University Of Maryland Analytical micro-devices for mental health treatment monitoring
CN103520766A (zh) * 2013-09-25 2014-01-22 高敏 贻贝粘蛋白液体产品、其制备方法及其应用
WO2015174643A1 (ko) * 2014-05-15 2015-11-19 포항공과대학교 산학협력단 표면 처리된 나노섬유를 포함하는 하이드로젤 및 이의 제조방법
KR101783448B1 (ko) * 2014-05-15 2017-09-29 포항공과대학교 산학협력단 표면 처리된 나노섬유를 포함하는 하이드로젤 및 이의 제조방법
CN104004231A (zh) * 2014-06-12 2014-08-27 东南大学 一种生物大分子互穿网络水凝胶及其制备方法
CN104013990A (zh) * 2014-06-18 2014-09-03 海南建科药业有限公司 具有儿茶酚基改性的壳聚糖及其制成的生物医学材料
KR101576503B1 (ko) 2015-04-03 2015-12-11 주식회사 이노테라피 카테콜 기 및 산화된 카테콜 기가 도입되어 가교된 키토산으로 코팅된 무출혈 주사바늘

Also Published As

Publication number Publication date
JP6410988B2 (ja) 2018-10-24
BR112017020978A2 (pt) 2018-07-10
BR112017020978B1 (pt) 2021-05-11
WO2016159734A1 (ko) 2016-10-06
CN107530477A (zh) 2018-01-02
KR101576503B1 (ko) 2015-12-11
MX2017012688A (es) 2018-04-11
CA2980116C (en) 2019-04-30
EP3278820A4 (en) 2018-12-05
AU2016241211B2 (en) 2019-02-14
ES2767717T3 (es) 2020-06-18
IL254614B (en) 2021-03-25
CN111603617B (zh) 2022-05-24
US9931443B1 (en) 2018-04-03
EP3278820A1 (en) 2018-02-07
EP3278820B1 (en) 2019-11-27
JP2018510750A (ja) 2018-04-19
IL254614A0 (en) 2017-11-30
RU2674704C1 (ru) 2018-12-12
US20180085500A1 (en) 2018-03-29
CN111603617A (zh) 2020-09-01
AU2016241211A1 (en) 2017-10-12
CA2980116A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
SA517390074B1 (ar) إبرة حقن لوقف النزف مغلفة بكيتوزان مرتبط تشابكياً بها مجموعة كاتيكول ومجموعة كاتيكول مؤكسدة
MX2021010528A (es) Metodos y composiciones para el tratamiento de las ulceras.
MX2017010734A (es) Terapia de combinacion con factores de coagulacion y anticuepos multiespecificos.
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
MX2018011088A (es) Composicion farmaceutica que comprende empagliflozina y sus usos.
MX2019005435A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
MX2016003922A (es) Copolimeros de silicona-polieter, adhesivos y articulos medicos que los comprenden, y metodos para elaborarlos.
WO2016086088A3 (en) Wound healing through sirt1 overexpression
WO2019006005A3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
EP3600150A4 (en) SUBCUTANE VASCULAR ARRANGEMENTS FOR IMPROVING BLOOD FLOW AND RELATED DEVICES AND METHODS
MX2019005401A (es) Metodos para tratar el sindrome de alport con bardoxolona metilo o analogos de la misma.
EP3703627A4 (en) SUCUTANEOUS VASCULAR SETS FOR IMPROVING BLOOD CIRCULATION AND ASSOCIATED DEVICES AND PROCEDURES
EP3277338A4 (en) Cannula system with sterile connector, blood pump, and patient harness
TW201613592A (en) Glucose metabolism ameliorating agent
WO2015106295A3 (en) Enolase 1 (eno1) compositions and uses thereof
MX359029B (es) Procedimiento para el tratamiento de enfermedades relacionadas con el factor inducible por hipoxia (hif) -.
NZ729181A (en) Treatment of disease with poly-n-acetylglucosamine nanofibers
MX2018002298A (es) Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos.
PH12017502145A1 (en) Composition and uses thereof
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
WO2014066400A3 (en) Methods for the effective treatment of metastatic cancer
MX2018013203A (es) Ciclodextrinas como procoagulantes.
WO2017079403A3 (en) Polymeric nanoparticles
WO2015130840A3 (en) Treatment of resistant lesions
WO2015170286A3 (en) Modulation of blood glucose levels